Gene-editing treatment poised for first US approval to work inside the body
⏮ BeforeEarlier CRISPR treatments require removing a participant's cells first.
✅ NowA new therapy alters genes inside the body and is poised for first FDA approval.
In short
- Earlier CRISPR treatments require removing a participant's cells first.
- That removal step is complex and costly.
- The new approach alters genes inside the body and is poised for first FDA approval.
Why it's good news
Earlier CRISPR treatments take cells out of the body, edit them, and return them, which is complex and expensive. A therapy that edits genes inside the body would skip that step. The source says the therapy is poised for approval, not that it has been approved.
Advertisement
From Nature
Nature, Published online: 12 November 2026; doi:10.1038/d41586-026-03705-9 Earlier CRISPR treatments require removal of a participant’s cells, a complex and costly approach.
Ask this story
More like this
Advertisement